First Wave Bio Has Received A Notice Of Allowance For Its U.S. Patent Application 17/163,996 Titled "Methods And Compositions For Treating Conditions Associated With An Abnormal Inflammatory Response"
Portfolio Pulse from Benzinga Newsdesk
First Wave Bio has received a Notice of Allowance for its U.S. patent application 17/163,996, titled 'Methods and Compositions for Treating Conditions Associated with an Abnormal Inflammatory Response'.

June 15, 2023 | 4:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
First Wave Bio's patent application approval may lead to new treatments for conditions associated with abnormal inflammatory responses.
The Notice of Allowance for First Wave Bio's patent application indicates that the company has successfully protected its intellectual property for methods and compositions related to treating conditions associated with abnormal inflammatory responses. This may lead to the development of new treatments and products, potentially increasing the company's revenue and positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100